Your browser doesn't support javascript.
loading
Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion.
Desai, Poonam N; Wang, Bofei; Fonseca, Andre; Borges, Pamella; Jelloul, Fatima Zahra; Reville, Patrick K; Lee, Eric; Ly, Christopher; Basi, Akshay; Root, Jessica; Baran, Natalia; Post, Sean M; Deng, Qing; Sun, Hanxiao; Harmanci, Arif O; Burks, Jared K; Gomez, Javier A; DiNardo, Courtney D; Daver, Naval G; Alatrash, Gheath; Konopleva, Marina; Green, Michael R; Antunes, Dinler A; Futreal, Andrew; Hao, Dapeng; Abbas, Hussein A.
Afiliación
  • Desai PN; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang B; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Fonseca A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Borges P; Department of Biology and Biochemistry, University of Houston, Houston, Texas.
  • Jelloul FZ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Reville PK; Department of Biology and Biochemistry, University of Houston, Houston, Texas.
  • Lee E; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ly C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Basi A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Root J; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Baran N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Post SM; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Deng Q; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sun H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Harmanci AO; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Burks JK; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gomez JA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • DiNardo CD; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Alatrash G; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Green MR; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Antunes DA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Futreal A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hao D; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Abbas HA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer Immunol Res ; : OF1-OF18, 2023 Jun 07.
Article en En | MEDLINE | ID: mdl-37285177
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Immunol Res Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Immunol Res Año: 2023 Tipo del documento: Article